SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our ...
(MENAFN- GlobeNewsWire - Nasdaq) Payer access for EmrosiTM expanded from approximately 100 million commercial lives to over 150 million commercial lives as of April 1, 2026 SCOTTSDALE, Ariz., April 21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results